Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OmniReliant Holdings has acquired the rights to a unique patented topical pharmaceutical product capable of delivering salicylic acid in a non-stick clear solid composition to treat acne.
Subscribe to our email newsletter
OmniReliant will use the patented product to compliment the company’s patent pending warming foam acne treatment product. Lead scientists William Bess and Leonard Mackles, who conceived the product, have agreed to sell the patent and collaborate with OmniReliant Holdings, to bring this breakthrough formula to the highly competitive acne treatment market.
Paul Morrison, CEO of OmniReliant, said: “We believe this patent enhances our portfolio by adding the knowledge of respected academics and allows OmniReliant to bring unique products to market that can make a difference.”